retatrutide vs. tirzepatide vs Tirzepatide: Best Triple Agonist Guide 2026 Retatrutide vs Tirzepatide: Key Differences

PHQ-9, Patient Health Questionnaire 9

In contrast, resmetirom (Rezdiffra) received FDA approval in 2024 specifically for noncirrhotic NASH with F2F3 fibrosis

Step 6: Engage in Shared Decision-Making Actively involve the patient in the treatment decision

It has been demonstrated that in animals with ALDH4A1 mutation, vitamin E and vitamin C supplementation can reverse the inhibition of ATPase activity by hyperprolinemia, and appropriate use of antioxidants can also be helpful to reduce neurotoxicity [19]

Regulatory agencies continue to emphasize the importance of mental health monitoring for all GLP-1 receptor agonists, recommending regular screening for depression and suicidal ideation

Sanofi Sun Pharmaceutical Industries Ltd